Ledger.Open graph →
SEC Form D · filed September 12, 2019

Faraday Pharmaceuticals, Inc

Offering
$30.1M
Sold
$25.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Adam G. Yader · Monterey, CAExecParker Spann · St. Louis, MOExecAndrew Hersant · George Town, Cayman IslandsDirector · PromoterD. J. Harder · Calgary, Alberta, CanadaDirectorCandace J. Woods · Newark, NJDirectorDavid Richardson · George Town, Cayman IslandsExec · DirectorJason G. Klarreich · New York, NYDirectorJanet Kraus · WALTHAM, MADirectorDerek Ohly · WALTHAM, MAExecAndreas Guldin · WALTHAM, MAExecElizabeth Campbell · Long Island City, NYDirectorJoseph Luceri · Long Island City, NYDirector · PromoterScott Perricelli · Long Island City, NYExec · DirectorRobert Halmi · YONKERS, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗